A brief presentation of The TERA Foundation

Similar documents
ACCELERATORS FOR HADRONTHERAPY

PROGRESS IN HADRONTHERAPY

III. Proton-therapytherapy. Rome SB - 5/5 1

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

By Elizabeth Clements. Applications in cancer treatment

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

New Treatment Research Facility Project at HIMAC

Future upcoming technologies and what audit needs to address

Hampton University Proton Therapy Institute

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Heavy Ion Tumor Therapy

Medical- and Radiation Physics Research at Surrey

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

IN VIVO IMAGING Proton Beam Range Verification With PET/CT

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

Two-Dimensional Thermoluminescence Dosimetry System for Proton Beam Quality Assurance

Review of Heavy Ion Accelerators for Hadrontherapy

Introduction to Ion Beam Cancer Therapy

Task Test beam infrastructure in Frascati LNF, Ferrara & Perugia INFN structure and University of Bergen

Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film

Image Guided Proton Therapy and Treatment Adaptation

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Your co-operation partner for research. EUROPEAN UNION European Regional Development Fund

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section

Review of Hadron machines for cancer therapy

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Changing Paradigms in Radiotherapy

Efficient Dosimetry for Proton Therapy

Status of Hadrontherapy facilities worldwide

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

Recent advances in dosimetry in reference conditions for proton and light-ion beams

Ion radiography as a tool for patient set-up & image guided particle therapy: a Monte Carlo study

Real Time Spectrometer for thermal neutrons from Radiotherapic Accelerators

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

HADRONTHERAPY: a new frontier for cancer treatment

Applications of Particle Accelerators

Activities at the Heidelberg Ion Therapy Center (HIT)

Nuclear Physics in Proton Radiotherapy

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN

Medical Applications with Laser Plasma Accelerators

Intensity Modulated RadioTherapy

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

High brightness electron beam for radiation therapy A new approach

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

SIMULATION RESPONSE OF RESISTIVE PLATE CHAMBER FOR FAST NEUTRONS USING GEANT4 MC CODE

Treatment Planning (Protons vs. Photons)

Basic Press Information


Ion Beam Therapy should we prioritise research on helium beams?

Dosimetry and QA of proton and heavier ion beams

Application of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint

Amendment No. 2. Item No. 2 (Rfx/ Event number )

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS

Dependence of the thermoluminescent high-temperature ratio (HTR) of LiF:Mg,Ti detectors on proton energy and dose

SUMITOMO Particle Therapy Technologies

UK X-FEL National Laboratory Perspective

Proton and helium beams: the present and the future of light ion beam therapy

IRRADIATION ACTIVITY WITH THE TOP-IMPLART PROTON LINEAR ACCELERATOR

Progress of Heavy Ion Therapy

Inhomogeneous Tissue Studies for Clinical Proton Therapy:

ClearPEM-Sonic: a multimodal PET-ultrasound mammography system

STEREOTACTIC DOSE VERIFICATION PHANTOM VERSATILE STEREOTACTIC QA PHANTOMS

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

Cancer: A Medical Challenge for Physics

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS

X-ray Safety Discussion and Tour for Health Physicists

TomoTherapy. Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA. May 2016

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

FIRST PATIENTS TREATMENT AT GSI USING HEAVY-ION BEAMS

Imaging of Radiation Dose Using Cherenkov Light

Biological Optimization of Hadrontherapy. Uwe Oelfke

MAESTRO: Methods and Advanced Equipment for Simulation and Treatment in Radiation Oncology

Clinical Precision for Best Cancer Care. Dee Mathieson Senior Vice President Oncology Business Line Management

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

I. Equipments for external beam radiotherapy

Verification of micro-beam irradiation

Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.

A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.

UK High Energy Physics developments for radiotherapy. Tony Price University of Birmingham PP Seminar 28 th September 2016

Spatially Fractionated Radiation Therapy: GRID Sponsored by.decimal Friday, August 22, Pamela Myers, Ph.D.

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry

The title of the presentation is: Neutron production with clinical LINACs for BNCT studies in physical, medical and biological fields.

The DAΦNE Beam Test Facility & AGILE Calibration

HEAVY PARTICLE THERAPY

Imaging in Radiotherapy

Particle Therapy- Why?

State-of-the-art proton therapy: The physicist s perspective

UK FEL R&D Plans Jim Clarke

RADIATION MONITORING DEVICES R A D I A T I O N P R O T E C T I O N & B I O L O G Y - R H O D E S

Transcription:

A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA

TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac Group - supervised by Prof. F. Sauli - 3 students - 1 post-doc - involved in several European projects PARTNER, ENVISION, and INTERVISION - 4 students - 2 engineers - Main projects are Caboto, TULIP, Idra... - Also involved in European projects... PARTNER 2

TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac Group - supervised by Prof. F. Sauli - 3 students - 1 post-doc - involved in several European projects PARTNER, ENVISION, and INTERVISION - 4 students - 2 engineers - Main projects are Caboto, TULIP, Idra... - Also involved in European projects... PARTNER TERA s administration is in Novara, Italy, while both groups carry out their research on the CERN Meyrin site (building 182). 3

Cyclinac Group The hadrontherapy community requires accelerating structures that are compact, have a high reliabilty, and appropriate beam parameters: 4

Cyclinac Group The hadrontherapy community requires accelerating structures that are compact, have a high reliabilty, and appropriate beam parameters: - active energy modulation - high repetition rate 3D spot scanning beam delivery with multipainting 5

Cyclinac: cyclotron + high freq linac Cell Coupled Linac Standing-wave structure RF frequency: 5.7 GHz 2.5 ms-long pulse at 300 Hz 6

TULIP: TUrning LInac for Protontherapy cyclotro n RF rotating joints RF Power sources C-band linac Section 1 W 0 W 1 C-band linac Section 2 SM 1 W 2 Line with 2% momentum acceptance SM 2 Beam dose delivery Cell Coupled Linac Standing-wave structure RF frequency: 5.7 GHz 2.5 ms-long pulse at 100 Hz 7

Test Cavities These structures operate at high-gradient and have similar high requirements on reliability as CLIC. Such structures must be tested... 8

Test Cavities These structures operate at high-gradient and have similar high requirements on reliability as CLIC. Such structures must be tested... S-band: 3 GHz One 3 GHz TERA Single-Cell Cavity already high-power tested C-band: 5.7 GHz Three 5.7 GHz TERA Single-Cell Cavities 2 conventional maching and 1 diamond machining 9

Why do we need Quality Assurance? The use of protons or ions as a radiotheraputic beam requires a higher precision in the correct delivery of the prescibed treatment plan. 10

Why do we need Quality Assurance? The use of protons or ions as a radiotheraputic beam requires a higher precision in the correct delivery of the prescibed treatment plan. 11

Why do we need Quality Assurance? The use of protons or ions as a radiotheraputic beam requires a higher precision in the correct delivery of the prescibed treatment plan. Uncertainties may arise from: Dose delivery uncertainties Delivery system Beam modelling CT units and range Spatial uncertainties Patient positioning Target delineation Organ motion Patient anatomy, motion, repositioning 12

The AQUA Overview Envision WP3 CNAO, PSI, MGH, AGH Un. Envision WP2 13

Proton Range Radiography Principle Energy loss of each proton is proportional to the integrated relative electron density of the target 14

Proton Range Radiography Principle Energy loss of each proton is proportional to the integrated relative electron density of the target Implementation Use a diagnostic monoenergetic beam of higher energy and lower intensity Measure each proton s position and residual range Build the 2D integrated density image: a proton radiograph 15

Proton Range Radiography Purposes of 2D PRR Optimal patient positioning (low dose radiography) Treatment planning verification CT Scan First step towards Proton CT Simulation PRR Realization N. Depauw and J. Seco, Phys. Med. Biol. 56 (2011) 2407-2421 First Proton Range Radiography prototype PRR10 (2010) 16

U. Amaldi et al, Nucl. Instr. and Meth. A629(2011)337 PSI PRR10 Beam Tests CNAO 1 mm Ø Lung (.20) Trabecular bone (1.16) Breast 50/50 (.99) 17

U. Amaldi et al, Nucl. Instr. and Meth. A629(2011)337 PSI PRR10 Beam Tests CNAO 1 mm Ø Lung (.20) Trabecular bone (1.16) Breast 50/50 (.99) For 1x1 mm 2 pixels and an image size of 30x30 cm 2 (10 5 pixels) 10 7 proton tracks to be recorded (possible in 10 seconds with 1 MHz readout rate) 18

U. Amaldi et al, Nucl. Instr. and Meth. A629(2011)337 PSI PRR10 Beam Tests CNAO 1 mm Ø Lung (.20) Trabecular bone (1.16) Breast 50/50 (.99) For 1x1 mm 2 pixels and an image size of 30x30 cm 2 (10 5 pixels) 10 7 proton tracks to be recorded (possible in 10 seconds with 1 MHz readout rate) Present R&D Larger area (30x30 cm 2 ) 48 scintillators (~ 15 cm tissue equivalent) Faster readout electronics ~ 1 MHz 19

U. Amaldi et al, Nucl. Instr. and Meth. A629(2011)337 PSI PRR10 Beam Tests CNAO 1 mm Ø Lung (.20) Trabecular bone (1.16) Breast 50/50 (.99) For 1x1 mm 2 pixels and an image size of 30x30 cm 2 (10 5 pixels) 10 7 proton tracks to be recorded (possible in 10 seconds with 1 MHz readout rate) Present R&D Larger area (30x30 cm 2 ) 48 scintillators (~ 15 cm tissue equivalent) Faster readout electronics ~ 1 MHz PRR30 in construction 20

Under construction: PRR30 Range Finder 48 Plastic scintillators 3mm each (15cm water equ) WLS fiber to SiPM ADC readout triggered by 2 scintillators in coincidence 21

Under construction: PRR30 Range Finder 48 Plastic scintillators 3mm each (15cm water equ) WLS fiber to SiPM ADC readout triggered by 2 scintillators in coincidence 30MeV to 190MeV Residual Energy 22

Under construction: PRR30 Range Finder 48 Plastic scintillators 3mm each (15cm water equ) WLS fiber to SiPM ADC readout triggered by 2 scintillators in coincidence 30MeV to 190MeV Residual Energy Tracker Two 30x30cm triple-gem detectors 2D XY strip readout (400um pitch) Readout electronics capable of 1M events/sec 23

Under construction: PRR30 Range Finder 48 Plastic scintillators 3mm each (15cm water equ) WLS fiber to SiPM ADC readout triggered by 2 scintillators in coincidence 30MeV to 190MeV Residual Energy Tracker Two 30x30cm triple-gem detectors 2D XY strip readout (400um pitch) Readout electronics capable of 1M events/sec New development was needed! 24

High-speed GEM readout New developments in GEM readout technology Main goal: ~ 1 MHz DATA THROUGHPUT 25

High-speed GEM readout New developments in GEM readout technology Main goal: ~ 1 MHz DATA THROUGHPUT Novel dedicated ASIC for GEM chambers GEMROC Hybrid Front End board developed by AGH Cracow University in collaboration with TERA 26

Conclusions - TERA Foundation is involved in hadrontherapy research directed by Prof. Ugo Amaldi 27

Conclusions - TERA Foundation is involved in hadrontherapy research directed by Prof. Ugo Amaldi - TERA has it s office in Novara but carries out its research at CERN 28

Conclusions - TERA Foundation is involved in hadrontherapy research directed by Prof. Ugo Amaldi - TERA has it s office in Novara but carries out its research at CERN - TERA consists of 7 students and 4 postdocs/engineers and a few senior ppl and administration 29

Conclusions - TERA Foundation is involved in hadrontherapy research directed by Prof. Ugo Amaldi - TERA has it s office in Novara but carries out its research at CERN - TERA consists of 7 students and 4 postdocs/engineers and a few senior ppl and administration - TERA s main projects are CABOTO, TULIP, PRR10, PRR30, IVI 30

Conclusions - TERA Foundation is involved in hadrontherapy research directed by Prof. Ugo Amaldi - TERA has it s office in Novara but carries out its research at CERN - TERA consists of 7 students and 4 postdocs/engineers and a few senior ppl and administration - TERA s main projects are CABOTO, TULIP, PRR10, PRR30, IVI - The TERA Foundation would benefit highly from a medical beam facility located at CERN 31

Backup Slides 32

Relative dose [%] Why Hadrontherapy? X-ray gamma neutron proton carbon 10 million habitants (20000pts/ year) Depth in water [cm] Protons and ions deposit the bulk of their energy at the end of their range in the Bragg peak. -better conformity of dose distribution Hoffmann, -Higher RBE at tumour site PPARC 2005 -lower dose to healthy tissues both on entry and exit channels 12% of Xray patients (2400pts/year) Hoffmann, PPARC 2005 33

In-beam PET Proton and ion therapy results in B+ activation of tissues which can be measured by a PET detector and used to verify the treatment plan immediately following irradiation 34

In-beam PET Detectors In-beam PET using mrpc In-beam PET using crystals 35